Antonio Rispo

Plain English
Researchers looked at how well GPT-5, a type of artificial intelligence, can interpret medical reports for inflammatory bowel disease (IBD), which includes Crohn's Disease and Ulcerative Colitis. In a study of 100 real patient reports, GPT-5 was more accurate than human experts, achieving 76% accuracy compared to 68.6% for specialized pathologists and lower for non-experts. This matters because using reliable AI like GPT-5 can help improve diagnosis and care, especially in places where expert specialists are not available. Who this helps: Patients who need accurate diagnoses for inflammatory bowel disease.

Plain English
This study focused on the effectiveness and safety of the medication Risankizumab for patients with Crohn's disease. Researchers looked at 520 patients and found that 60.8% were symptom-free after 12 weeks, and by 52 weeks, 65.6% remained free of steroid use, with 37.5% showing improvement in their intestinal condition. These findings show that Risankizumab provides significant relief for patients who have had trouble with other treatments. Who this helps: This helps patients with Crohn's disease, particularly those who haven't responded well to other medications.

Plain English
This study looked at whether early improvements in intestinal ultrasound measurements could predict healing in patients with Crohn's disease after they started biological therapy. They found that after 12 months, 19% of patients showed significant healing, and those who improved early had better ultrasound results; specifically, a decrease in bowel wall thickness (BWT) of 1.25 mm could predict healing with 73% accuracy. This is important because using this simple ultrasound tool can help doctors make better treatment decisions early on. Who this helps: Patients with Crohn's disease and their doctors.

Plain English
This study looked at a condition called segmental colitis associated with diverticulosis (SCAD) in patients undergoing colorectal cancer (CRC) screening. They found that about 5% of people screened had SCAD, and those with SCAD had lower rates of adenomas (32%) compared to those with uncomplicated diverticulosis (47%). This matters because understanding the prevalence of SCAD and its lower association with precancerous growths can help doctors better manage and monitor patients with diverticulosis. Who this helps: This helps patients with diverticulosis and their doctors.

Plain English
This research validated a tool called IBD-Disk, which helps assess the level of disability in patients with inflammatory bowel disease (IBD) in Italy. The study included 767 patients and found that the IBD-Disk scores had strong consistency and validity, correlating well with other established measures of disability and quality of life (with scores of 0.70 and 0.83 respectively). This tool is important because it can improve how doctors assess and manage disability in IBD patients, making it easier to provide the right care. Who this helps: Patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at how often ulcers appear in patients with Crohn's disease (CD) after surgery compared to those with colon cancer (CC). The researchers found that 57% of Crohn's patients developed postoperative recurrence (POR), while only 3% of colon cancer patients had ulcers at the surgery site. This matters because it shows that the presence of ulcers may not indicate a true problem for Crohn's patients as it does in colon cancer patients, which could change how doctors evaluate postoperative issues. Who this helps: This helps patients with Crohn's disease and their doctors.

Plain English
This study looked at how a specialized clinic for inflammatory bowel disease (IBD) patients could speed up the diagnosis of extraintestinal symptoms compared to traditional specialist referrals. Patients at the specialized clinic received diagnoses in about 2.5 months, while those referred to individual specialists took an average of about 5.4 months. Faster diagnosis led to quicker treatment changes and more effective management of the disease. Who this helps: This benefits IBD patients experiencing extraintestinal symptoms.

Plain English
This study looked at the occurrence of acute pancreatitis (AP) in patients with inflammatory bowel disease (IBD) across Europe over ten years. It found that about 0.58% of IBD patients had AP, with most cases being mild, and drugs like azathioprine were the main cause in over half of the patients. Understanding these findings is important because they help identify which IBD patients are at risk for pancreatitis and how to manage their treatment more effectively. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

Plain English
This study examined a new method for diagnosing celiac disease by detecting specific immune cells in the blood of patients. Researchers found that patients with untreated celiac disease had many more activated CD4T cells that react to gliadin (the gluten protein) compared to people on a gluten-free diet or healthy individuals, with counts significantly higher in untreated patients. This new test could make diagnosing celiac disease easier and less invasive, which is important for those who struggle with traditional testing methods. Who this helps: This helps patients suspected of having celiac disease, especially those who might get inconclusive results from standard tests.

Plain English
This study investigated how quickly healthcare trainees can learn to use intestinal ultrasound (IUS) effectively for diagnosing inflammatory bowel disease (IBD). The researchers found that after training, trainees did well with basic skills but needed to complete between 75 to 112 examinations to become proficient in these techniques, with 37.5% to 62.5% of them reaching competency in basic parameters. Advanced skills took longer, with major improvements noted in diagnosing bowel dilation. Who this helps: This benefits patients with inflammatory bowel disease and their doctors by ensuring that proper diagnostic techniques are used in their care.

Plain English
Researchers adapted European quality care standards for inflammatory bowel disease (IBD) to better fit Italy's healthcare system. They started with 101 statements from the European Crohn's Colitis Organisation and created 112 tailored criteria for Italian care, confirming 80 of the original statements while adding 12 new ones. This is important because it aims to improve the consistency and quality of IBD treatment in Italy, which can lead to better patient outcomes. Who this helps: Patients with inflammatory bowel disease in Italy.

Plain English
Researchers studied the effectiveness of tofacitinib (TFB) in treating ulcerative colitis, focusing on patients with moderate to severe cases and acute severe ulcerative colitis. They found that 23.7% of patients achieved remission at 12 weeks and 41.1% at 52 weeks, with a higher rate of patients undergoing surgery in the acute severe group compared to those with chronic activity (17.6% vs. 5.7%). This is important because TFB can help many patients manage their symptoms better and avoid more invasive treatments. Who this helps: Patients with ulcerative colitis, especially those with severe cases.

Plain English
This study looked at how young people with inflammatory bowel disease (IBD) transition from pediatric to adult healthcare in Italy by surveying 104 doctors. They found that 91% of pediatric gastroenterologists prioritized a patient's disease status during this transition, while only 50% of adult gastroenterologists felt the same way. The main challenge for patients was the difficulty of leaving the supportive pediatric environment, which many doctors considered a significant barrier to a smooth transition. Who this helps: This helps patients transitioning to adult care and their doctors.

Plain English
This study looked at how partial enteral nutrition (PEN) can work alongside stronger biological treatments for adults with tough-to-treat Crohn's disease who have stopped responding to their usual medications. They found that 64.3% of patients using PEN achieved clinical remission after 24 weeks, compared to only 25% of those who just received biological therapy. This matters because using PEN not only led to better remission rates but also improved patients' nutrition, suggesting it could be a helpful addition to current treatments. Who this helps: This benefits adults with Crohn's disease who are struggling to find effective treatment.

Plain English
This study examined a rare condition called De Garengeot hernia, where an inflamed appendix is trapped in a femoral hernia. It occurs in 0.5% to 5% of all femoral hernia cases and can cause serious issues if the appendix becomes badly inflamed or dies, which happens in about 0.08% to 0.13% of these cases. Recognizing this condition before surgery can improve patient outcomes and help doctors identify the issue more reliably. Who this helps: Patients experiencing femoral hernias and healthcare providers diagnosing and treating them.

Plain English
This study focused on how to best manage patients who have both inflammatory bowel disease (IBD) and spondyloarthritis (SpA), a painful condition affecting the joints. Researchers developed 34 recommendations and 4 treatment plans to help doctors better treat these patients, as treatment options for both conditions have recently improved but lack specific trial data for their combined management. These guidelines aim to ensure that healthcare providers consider both intestinal and joint symptoms when creating treatment plans. Who this helps: This helps patients with both IBD and spondyloarthritis, as well as their doctors.

Plain English
The study evaluated a new method to diagnose coeliac disease in adults who were on gluten-free diets without a proper diagnosis. Researchers had 120 participants eat gluten-containing crackers for three months, and found that 45% tested positive for coeliac disease with a follow-up confirmatory procedure showing 87% had severe damage in their intestines. This approach was safe, with 83% of participants expressing satisfaction with the process, making it a promising option for diagnosing coeliac disease. Who this helps: This benefits patients who are unsure if they have coeliac disease while on a gluten-free diet.

Plain English
This study looked at different tests to diagnose coeliac disease in adults, specifically comparing two methods: one using anti-tissue transglutaminase and deamidated gliadin peptides, and the other using anti-endomysial antibodies and anti-tissue transglutaminase. Researchers found that the combined test of anti-tissue transglutaminase and deamidated gliadin peptides was nearly as effective as the other method, with 97% sensitivity and 100% specificity, compared to 94% sensitivity and 100% specificity for the alternative method. This is important because using the new combination test could lower costs and make the process easier for doctors. Who this helps: This helps patients suspected of having coeliac disease and the doctors who diagnose them.

Plain English
The study focused on how well doctors understand and manage other immune-related diseases that often occur alongside inflammatory bowel disease (IBD). It found that while 87.9% of doctors routinely ask about these other diseases during initial appointments, only 5.2% investigate during follow-up visits. The research highlights that even though doctors are aware of the importance of these related conditions, many face challenges that stop them from efficiently working together with other specialists. Who this helps: This benefits patients with inflammatory bowel disease who may also have other immune-related conditions.

Plain English
This study looked at how a gluten-free diet affects the activity of certain genes in patients with celiac disease. Researchers found that while the gene related to gluten presentation (HLA-DQ2.5) showed no change after a gluten-free diet, the expression of another gene (TRAFD1) increased significantly, suggesting it may help reduce inflammation caused by gluten. These findings are important because they enhance our understanding of how a gluten-free diet helps manage celiac disease and could lead to better dietary guidelines. Who this helps: This helps patients with celiac disease and their healthcare providers.

Plain English
This study looked at how prepared young people with inflammatory bowel disease (IBD) are to switch from pediatric to adult healthcare, and how that readiness affects their health outcomes. Researchers found that 54 out of 80 patients were ready to transition and those who were ready experienced fewer health problems and hospital visits after a year. This is important because it shows that being prepared for this transition can lead to better health results, highlighting the need for targeted support for young patients. Who this helps: This helps young patients with IBD and their doctors.

Plain English
This study looked at how a specific surgical connection technique, called Kono-S anastomosis, affects the quality of life for patients with Crohn's disease after they undergo surgery to remove part of their intestine. Researchers found that, out of 94 patients, those who had the Kono-S technique reported better results in terms of bowel symptoms and social function; specifically, their average scores were 56.3 and 26.5, compared to 50.7 and 23.5 for those with the standard technique, showing significant improvements. This matters because better quality of life can lead to improved overall well-being for patients suffering from Crohn's disease after surgery. Who this helps: Patients with Crohn's disease undergoing ileocolic resection.

Plain English
This study looked at how inflammatory bowel disease (IBD) affects the kidneys, finding that around 25% of IBD patients experience kidney issues, such as kidney stones and kidney inflammation. It highlights that conditions like IgA nephropathy can arise due to the connection between gut and kidney health. Understanding this relationship is essential because it can lead to better management of kidney problems in IBD patients and potentially prevent serious complications like kidney failure. Who this helps: Patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at how well selective JAK inhibitors (a type of medication) work in patients with ulcerative colitis (UC) and Crohn's disease (CD) who have already tried other treatments. Out of 246 patients, 76.2% of those with CD and 59.5% of those with UC saw significant improvement in their symptoms after a few weeks. After 52 weeks, 66.7% of CD patients and 86.2% of UC patients maintained their improvement, making these medications a promising option for tougher cases. Who this helps: This helps patients with ulcerative colitis and Crohn's disease who have not responded well to other treatments.

Plain English
This study looked at how inflammatory bowel diseases (IBDs) affect people's jobs and overall quality of life. Researchers surveyed 216 patients and found that only 53% were employed, with an average of 10% missing work and 37% facing difficulties at work due to their condition. Many patients also reported significant impairments in daily activities and a lower quality of life score of 47 out of 100. These findings show that IBD can significantly hinder a person’s ability to work and live well. Who this helps: This information benefits patients with IBD and their healthcare providers by highlighting the need for better support and treatment options.

Plain English
This study compared two methods for diagnosing Crohn's disease: handheld bowel sonography (HHBS) and magnetic resonance enterography (MRE). Of the 85 patients tested, Crohn's disease was diagnosed in 48 (56%). While both methods were accurate, MRE was slightly better at identifying the extent and complications of the disease, with 92.94% accuracy compared to 89.41% for HHBS. This matters because using HHBS could help quickly identify patients who need further testing with MRE, streamlining the diagnosis process. Who this helps: Patients suspected of having Crohn's disease.

Plain English
This study looked at whether hand-held intestinal ultrasound (HHIUS) can accurately assess the severity and extent of ulcerative colitis (UC), comparing it to traditional intestinal ultrasound (IUS). Researchers examined 86 UC patients and found that both methods gave similar results regarding disease activity, with an agreement score of 0.86, indicating they are highly reliable. This is important because HHIUS is a simpler and less invasive way to monitor UC, allowing for quicker treatment decisions while saving time and money. Who this helps: This helps patients with ulcerative colitis and their doctors.

Plain English
This study looked at two patients who were mistakenly diagnosed with Crohn's disease but actually had a condition called cyclic neutropenia, which causes low levels of a type of white blood cell. The patients had symptoms like oral ulcers and infections; after surgery, doctors identified the real issue and started treatment with granulocyte colony-stimulating factor (G-CSF), which helped improve their condition. This matters because correctly diagnosing the problem can lead to better treatment and avoid unnecessary surgeries. Who this helps: This helps patients with cyclic neutropenia and healthcare providers involved in diagnosing gastrointestinal issues.

Plain English
This study looked at how advances in medical techniques improve the removal of precancerous growths in patients with inflammatory bowel disease (IBD), which puts them at a higher risk for colorectal cancer. Researchers found that new imaging technologies and endoscopic methods could successfully identify and remove these growths, reducing the need for more invasive surgeries and improving long-term health outcomes for patients. Specifically, techniques like endoscopic mucosal resection and endoscopic submucosal dissection have made a significant impact on managing these risks. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at how effective bowel ultrasonography (BUS) is in tracking improvements in patients with Crohn’s disease (CD) after they received different biological therapies. Out of 201 patients, 188 were evaluated, and the results showed that about 27.5% of these patients experienced complete healing of their bowel by 12 months. Improvements in bowel wall thickness were significant, and common indicators of disease activity decreased over the year, meaning BUS could be a helpful tool for doctors to monitor treatment success in CD patients effectively. Who this helps: This helps patients with Crohn's disease and their doctors.

Plain English
This study looked at people with Crohn's disease who had surgery and aimed to find out what factors might lead to complications after the operation. Among the 165 patients studied, 42 (25.5%) experienced problems afterward, with the most common issues being infections and prolonged recovery times. Knowing the key factors, like surgery duration and preoperative care, can help doctors improve patient outcomes by lowering the chances of complications. Who this helps: This information benefits patients with Crohn's disease and their doctors.

Plain English
This study examined a rare type of bowel blockage in adults called ileo-ileal intussusception, caused by a specific benign tumor known as Vanek's tumor. The researchers highlighted that while intussusception is more common in children, it can also occur in adults, particularly those over 50, often due to tumors. The case identified showed that ultrasound can effectively diagnose this condition, which is important because timely diagnosis can lead to better treatment outcomes. Who this helps: This helps patients and doctors by improving diagnosis and management of bowel blockages caused by tumors.

Plain English
This study investigated a new scoring system called the Simplified Histologic Mucosal Healing Scheme (SHMHS) to evaluate healing in patients with inflammatory bowel disease (IBD). Researchers analyzed data from 597 patients and found that the average SHMHS score was 2.96, indicating that 66.8% of patients still had active disease. These findings matter because they show that SHMHS can effectively measure intestinal health, helping doctors make better treatment decisions while reducing their workload. Who this helps: Patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at how intestinal ultrasound (IUS) helps in managing inflammatory bowel disease (IBD), especially Crohn's disease and ulcerative colitis. It found that using IUS allows doctors to monitor changes in the disease more effectively and can help them adjust treatments faster, which could reduce the need for invasive procedures like endoscopies. The most useful measure from IUS is the thickness of the bowel wall, and improving methods to assess disease activity will help make IUS a regular part of patient care. Who this helps: This benefits patients with inflammatory bowel disease by providing more accurate and less invasive monitoring and treatment options.

Plain English
This study focused on understanding "deep remission" in patients with Crohn's disease (CD) by looking at how well inflammation is controlled in both the gut lining and deeper layers of the intestinal wall. Researchers found that among 118 CD patients, only 33 (about 28%) achieved a state of deep remission, which involves low levels of specific biomarkers and healing of both the lining and deeper tissues. This matters because attaining deep remission might significantly improve patient outcomes and quality of life. Who this helps: Patients with Crohn's disease.

Plain English
This study examined the effects of sarcopenia, or loss of muscle mass, on people with Crohn's disease, particularly how it influenced their health outcomes. Out of 63 patients, 68.3% were found to have sarcopenia, which was linked to a significantly higher rate of infections (42% for those with sarcopenia compared to 15% for those without). Although sarcopenia did not significantly affect surgery rates, the study highlights that better understanding and treatment of muscle loss in Crohn's patients could improve their health. Who this helps: This helps patients with Crohn's disease and their doctors.

Plain English
This study examined how certain imaging results from MR-enterography (MRE) can predict whether Crohn's disease patients will need medical or surgical treatment after one year. Researchers found that out of 70 patients, 57 (about 81%) continued with medical treatment, while 13 (about 19%) required surgery. Specifically, higher values of a measure called ADCmean were associated with patients who could successfully manage their condition through medication, while the presence of strictures indicated a need for surgery. Who this helps: This information is beneficial for doctors treating Crohn's disease patients, as it can guide them in deciding between medical and surgical management.

Plain English
This study looked at the risk of infections in patients with inflammatory bowel disease (IBD) who were treated with anti-TNF-α medications compared to those who received nonbiological treatments. They found that 20.1% of patients on anti-TNF-α experienced infections, while only 8% of those on other treatments did, meaning anti-TNF-α patients were about three times more likely to get infections. Serious infections also occurred more frequently in the anti-TNF-α group, with an incidence rate of 1.3 per 100 patient-years compared to 0.38 in the nonbiological group. Who this helps: This information is important for patients with IBD and their doctors in managing treatment choices and monitoring infection risks effectively.

Plain English
This study looked at the connection between Crohn's disease and Takayasu's arteritis, two serious immune-related conditions, especially in young women. The researchers found three cases of young women suffering from both diseases, highlighting that while it's rare, having both conditions can complicate diagnosis and treatment. They emphasize the importance of detecting these diseases early to improve patient care and potentially develop common treatment approaches. Who this helps: This helps doctors and patients dealing with both Crohn's disease and Takayasu's arteritis.

Plain English
This research looked at how ultrasound imaging can be used to diagnose and manage sclerosing mesenteritis (SM), a condition that causes swelling and inflammation in the abdominal tissue. The study found that ultrasound can effectively help doctors monitor the disease, allowing for better management of symptoms and treatment decisions. This matters because it provides a safer and less invasive way to track a condition that can cause serious health issues. Who this helps: This helps patients with sclerosing mesenteritis and their doctors.

Plain English
This study looked at patients with Crohn's disease who may not be suitable for anti-TNF treatments, which have been used for two decades but have limitations. The researchers interviewed 100 Italian doctors and found that about 9% of patients are unsuitable for these treatments due to health risks, while around 11% stopped treatment because of side effects. Notably, elderly patients and those with severe heart disease or other serious health issues were often deemed unsuitable, with 40 to 60% of these patients considered at risk. Who this helps: This benefits patients with Crohn's disease and their doctors by highlighting alternative treatment options for those who cannot safely use anti-TNF therapies.

Plain English
This study looked at how a substance called gliadin affects specific genes related to celiac disease in immune cells called macrophages from adult patients in the U.S. and Italy. Researchers found that after gliadin exposure, there was an increase in the gene related to the HLA-DQ2.5 risk factor (DQA1*05:01) and a decrease in another related gene (DQB1*02:01), indicating that gliadin influences how these genes are expressed. This is important because understanding how gliadin impacts gene expression helps clarify the immune response in celiac disease, which could lead to better treatments for patients. Who this helps: This helps patients with celiac disease and their doctors.

Plain English
This study looked at patients with coeliac disease (CD) and how often they develop fatty liver disease after starting a gluten-free diet. Of 221 patients, 65 (29.4%) had fatty liver when they were first diagnosed with CD, and 46.6% developed it after two years. The study also found that those with a new diagnosis of metabolic-associated fatty liver disease (MAFLD) had more insulin resistance and higher liver damage scores compared to those with non-alcoholic fatty liver disease (NAFLD), highlighting the need for closer monitoring of these patients. Who this helps: Patients with coeliac disease and their healthcare providers.

Plain English
This study looked at how a dedicated contact center helped patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic. Researchers found that the contact center received more calls—971 during the pandemic compared to 881 before it—and managed to keep clinical outcomes stable, with no changes in hospitalizations or treatments. This matters because it shows that patients could still receive essential care through phone consultations even when regular hospital visits were disrupted. Who this helps: This helps IBD patients by ensuring they can maintain access to healthcare during emergencies.

Plain English
This study looked at how well two medications—azathioprine (AZA) and high-dose 5-aminosalicylic acid (5-ASA)—could prevent the return of Crohn's disease symptoms in patients with serious inflammation after surgery. Over a year, 17.4% of participants faced treatment failure, and there was no significant difference between the two drugs in this outcome. However, those taking AZA had a better chance of improving their endoscopic scores, with 30% seeing improvement compared to just 11.8% on 5-ASA. Who this helps: This research benefits doctors treating Crohn's disease by providing insights into medication options for patients with severe post-operative symptoms.